164 related articles for article (PubMed ID: 15801922)
1. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.
Schwimmer JB; Middleton MS; Deutsch R; Lavine JE
Aliment Pharmacol Ther; 2005 Apr; 21(7):871-9. PubMed ID: 15801922
[TBL] [Abstract][Full Text] [Related]
2. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial.
Nair S; Diehl AM; Wiseman M; Farr GH; Perrillo RP
Aliment Pharmacol Ther; 2004 Jul; 20(1):23-8. PubMed ID: 15225167
[TBL] [Abstract][Full Text] [Related]
3. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.
Promrat K; Lutchman G; Uwaifo GI; Freedman RJ; Soza A; Heller T; Doo E; Ghany M; Premkumar A; Park Y; Liang TJ; Yanovski JA; Kleiner DE; Hoofnagle JH
Hepatology; 2004 Jan; 39(1):188-96. PubMed ID: 14752837
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial.
Torres DM; Jones FJ; Shaw JC; Williams CD; Ward JA; Harrison SA
Hepatology; 2011 Nov; 54(5):1631-9. PubMed ID: 21748770
[TBL] [Abstract][Full Text] [Related]
8. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being.
Moon RJ; Bascombe LA; Holt RI
Diabetes Obes Metab; 2007 Jan; 9(1):143-5. PubMed ID: 17199734
[TBL] [Abstract][Full Text] [Related]
9. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.
Fernández-Miranda C; Pérez-Carreras M; Colina F; López-Alonso G; Vargas C; Solís-Herruzo JA
Dig Liver Dis; 2008 Mar; 40(3):200-5. PubMed ID: 18261709
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
11. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Chazova I; Almazov VA; Shlyakhto E
Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study.
Lavine JE
J Pediatr; 2000 Jun; 136(6):734-8. PubMed ID: 10839868
[TBL] [Abstract][Full Text] [Related]
13. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.
Radetti G; Kleon W; Stuefer J; Pittschieler K
Acta Paediatr; 2006 Jul; 95(7):833-7. PubMed ID: 16801180
[TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.
Yakaryilmaz F; Guliter S; Savas B; Erdem O; Ersoy R; Erden E; Akyol G; Bozkaya H; Ozenirler S
Intern Med J; 2007 Apr; 37(4):229-35. PubMed ID: 17388862
[TBL] [Abstract][Full Text] [Related]
16. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis.
Aithal GP; Thomas JA; Kaye PV; Lawson A; Ryder SD; Spendlove I; Austin AS; Freeman JG; Morgan L; Webber J
Gastroenterology; 2008 Oct; 135(4):1176-84. PubMed ID: 18718471
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis.
Sajjad A; Mottershead M; Syn WK; Jones R; Smith S; Nwokolo CU
Aliment Pharmacol Ther; 2005 Aug; 22(4):291-9. PubMed ID: 16097995
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease.
Nobili V; Manco M; Devito R; Ciampalini P; Piemonte F; Marcellini M
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1553-61. PubMed ID: 17206944
[TBL] [Abstract][Full Text] [Related]
19. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
Dastjerdi MS; Kazemi F; Najafian A; Mohammady M; Aminorroaya A; Amini M
Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
[TBL] [Abstract][Full Text] [Related]
20. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
